|
⚲
|
| Keyboard |
| Richard Pascoe | |
|---|---|
| Firm | |
| Address | c/o Seelos Therapeutics, Inc 300 Park Avenue, 2nd Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Seelos Therapeutics Inc | 021-520127 | Director | of 1.1 M |
||
| Seelos Therapeutics Inc | 021-514857 | Director | of 2.0 M |
||
| Seelos Therapeutics Inc | 021-505332 | Director | of 3.6 M |
||
| Kempharm Inc | 021-403827 | Director | 39.1 M of 39.1 M |
||
| Kempharm Inc | 021-388500 | Director | 44.0 M of 44.0 M |
||
| Kempharm Inc | 021-386231 | Director | 31.5 M of 31.5 M |
||
| Histogen Inc | 021-380943 | Executive Officer | 0.2 M of 0.2 M |
||
| Seelos Therapeutics Inc | 021-375447 | Director | of 5.6 M |
||
| Kempharm Inc | 021-357863 | Director | 3.0 M of 3.0 M |
||
| Kempharm Inc | 021-356348 | Director | 71.4 M of 71.4 M |
||
| Seelos Therapeutics Inc | 021-347816 | Director | of 4.0 M |
||
| Kempharm Inc | 021-325008 | Director | 1.1 M of 1.1 M |
||
| Apricus Biosciences Inc | 021-295477 | Executive Officer | 3.7 M of 3.7 M |
||
| Apricus Biosciences Inc | 021-272379 | Executive Officer | 3.7 M of 3.7 M |
||
| Histogen Inc | 021-269733 | Executive Officer | 15.3 M of 30.0 M |
||
| Kempharm Inc | 021-235160 | Director | 4.0 M of 4.0 M |
||
| Somaxon Pharmaceuticals Inc | 021-89181 | Executive Officer | 6.0 M of 6.0 M |
||
| Related People Network |
|---|
| Network #281 at Histogen Inc — files alongside 11 co-filers |